New York, Aug. 4, 2022 (GLOBE NEWSWIRE) — The American Cancer Society estimates that there will be approximately 26,380 new cases of gastric cancer (also known as gastric cancer) in the United States in 2022 (15,900 in men and 10,480 in women). Also, about 1.5% of all new cancer cases identified in the United States each year are gastric malignancies.

Research Nester has assessed the current market opportunities in ‘Global Gastrointestinal Radiofrequency Ablation Systems Market‘ for the period, i.e. 2022 – 2031, including the ongoing industry trends and innovations that will help the industry players achieve their business goals. Apart from this, comprehensive data on market size, share and forecast, growth opportunities and challenges faced by the market players, as well as worldwide analysis on regions – North America, Latin America, Europe, Asia Pacific, and Middle East & Africa – has been provided in the report.

The global Gastrointestinal Radiofrequency Ablation Systems market is anticipated to grow at a CAGR of ~6% during the forecast period. The growth of the market is attributed to the increasing prevalence of gastric cancer, esophageal cancer and other tumors in the digestive system. According to the WHO, there were an estimated 4.8 million new cancer cases and 3.4 million deaths as a result in 2018; Gastrointestinal cancer accounts for 26% of cancer cases worldwide. In addition, the gastrointestinal radiofrequency ablation systems are used to carefully burn the mucosa of the gastrointestinal tract. This procedure eliminates any unnatural development in the digestive tract. The market will continue to grow due to the increasing investments in research and development activities around the world for novel drugs and technology development. According to research reports, global spending on research and development has increased from US$677 billion in 2000 to US$2.2 trillion in 2019. Also, the market…